ANN SURG:结肠癌术后粘连性肠梗阻发生率及危险因素

2018-06-30 MedSci MedSci原创

结肠切除术后肠梗阻对患者生活质量有显着影响并回增加医疗花费,但大部分针对术后肠梗阻的研究都为单中心数据。ANN SURG近期发表了一篇文章,使用韩国全国数据分析结肠癌术后粘连性肠梗阻发生率以及其危险因素。

结肠切除术后肠梗阻对患者生活质量有显着影响并回增加医疗花费,但大部分针对术后肠梗阻的研究都为单中心数据。ANN SURG近期发表了一篇文章,使用韩国全国数据分析结肠癌术后粘连性肠梗阻发生率以及其危险因素。

作者分析了2010年至2012年间接受结肠切除术的结肠癌患者,通过健康保险机构获得至少3年的随访数据。结肠切除术30天后需要接受鼻胃管或肠梗阻手术干预的患者定为存在术后肠梗阻。研究结果表明,术后3年内共3083例(12.5% )患者出现术后肠梗阻。Logistic回归分析表明术后肠梗阻的显着危险因素为高龄,男性,开腹结肠切除术以及低级别医院。3083例患者中,50.7%的患者在术后1年内出现第一次肠梗阻,7.8%的患者在术后3年内肠梗阻出现复发。根据高龄,男性,开腹手术,低级别医院等危险因素计算的3年术后肠梗阻累计发病率分别为14.6%,14.3%,19.5%和15.1%。

文章最后认为,该研究报道了结肠癌术后肠梗阻的发生率及危险因素。这些结果可以作为未来结肠切除术后预防肠梗阻的研究基础。

原始出处:
Seo Gi Hyeon,Choe Eun Kyung,et al.Incidence of Adhesive Bowel Obstruction After Colon Cancer Surgery and its Risk Factors:A National Claim Study.ANN SURG.July 2018 doi:10.1097/SLA.00000000000227

本文系梅斯医学(MedSci)原创编译整理,转载需授权!

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1826460, encodeId=093d18264606b, content=<a href='/topic/show?id=e5283e89970' target=_blank style='color:#2F92EE;'>#发生率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37899, encryptionId=e5283e89970, topicName=发生率)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30bd35, createdName=一叶知秋, createdTime=Fri Feb 22 22:03:00 CST 2019, time=2019-02-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1290095, encodeId=36ad12900950a, content=<a href='/topic/show?id=cea4815e119' target=_blank style='color:#2F92EE;'>#肠梗阻#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=81571, encryptionId=cea4815e119, topicName=肠梗阻)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c950224, createdName=hjwang79, createdTime=Mon Jul 02 04:03:00 CST 2018, time=2018-07-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=328238, encodeId=021032823886, content=学习了.谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Sat Jun 30 14:11:38 CST 2018, time=2018-06-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=328222, encodeId=a8af328222d1, content=优质资源.共同学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib06iaV3D9Tg5K0LqDY57Aia0TOQByoJhNt3icm4sfukp500hLH6RHOpFdV01NbECtAV7s0qKpQPibyRukQAwAmqJU3X/0, createdBy=f91f1928792, createdName=九九消寒, createdTime=Sat Jun 30 13:20:59 CST 2018, time=2018-06-30, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1826460, encodeId=093d18264606b, content=<a href='/topic/show?id=e5283e89970' target=_blank style='color:#2F92EE;'>#发生率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37899, encryptionId=e5283e89970, topicName=发生率)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30bd35, createdName=一叶知秋, createdTime=Fri Feb 22 22:03:00 CST 2019, time=2019-02-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1290095, encodeId=36ad12900950a, content=<a href='/topic/show?id=cea4815e119' target=_blank style='color:#2F92EE;'>#肠梗阻#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=81571, encryptionId=cea4815e119, topicName=肠梗阻)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c950224, createdName=hjwang79, createdTime=Mon Jul 02 04:03:00 CST 2018, time=2018-07-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=328238, encodeId=021032823886, content=学习了.谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Sat Jun 30 14:11:38 CST 2018, time=2018-06-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=328222, encodeId=a8af328222d1, content=优质资源.共同学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib06iaV3D9Tg5K0LqDY57Aia0TOQByoJhNt3icm4sfukp500hLH6RHOpFdV01NbECtAV7s0qKpQPibyRukQAwAmqJU3X/0, createdBy=f91f1928792, createdName=九九消寒, createdTime=Sat Jun 30 13:20:59 CST 2018, time=2018-06-30, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1826460, encodeId=093d18264606b, content=<a href='/topic/show?id=e5283e89970' target=_blank style='color:#2F92EE;'>#发生率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37899, encryptionId=e5283e89970, topicName=发生率)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30bd35, createdName=一叶知秋, createdTime=Fri Feb 22 22:03:00 CST 2019, time=2019-02-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1290095, encodeId=36ad12900950a, content=<a href='/topic/show?id=cea4815e119' target=_blank style='color:#2F92EE;'>#肠梗阻#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=81571, encryptionId=cea4815e119, topicName=肠梗阻)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c950224, createdName=hjwang79, createdTime=Mon Jul 02 04:03:00 CST 2018, time=2018-07-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=328238, encodeId=021032823886, content=学习了.谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Sat Jun 30 14:11:38 CST 2018, time=2018-06-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=328222, encodeId=a8af328222d1, content=优质资源.共同学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib06iaV3D9Tg5K0LqDY57Aia0TOQByoJhNt3icm4sfukp500hLH6RHOpFdV01NbECtAV7s0qKpQPibyRukQAwAmqJU3X/0, createdBy=f91f1928792, createdName=九九消寒, createdTime=Sat Jun 30 13:20:59 CST 2018, time=2018-06-30, status=1, ipAttribution=)]
    2018-06-30 1209e435m98(暂无昵称)

    学习了.谢谢分享

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1826460, encodeId=093d18264606b, content=<a href='/topic/show?id=e5283e89970' target=_blank style='color:#2F92EE;'>#发生率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37899, encryptionId=e5283e89970, topicName=发生率)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30bd35, createdName=一叶知秋, createdTime=Fri Feb 22 22:03:00 CST 2019, time=2019-02-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1290095, encodeId=36ad12900950a, content=<a href='/topic/show?id=cea4815e119' target=_blank style='color:#2F92EE;'>#肠梗阻#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=81571, encryptionId=cea4815e119, topicName=肠梗阻)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c950224, createdName=hjwang79, createdTime=Mon Jul 02 04:03:00 CST 2018, time=2018-07-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=328238, encodeId=021032823886, content=学习了.谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Sat Jun 30 14:11:38 CST 2018, time=2018-06-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=328222, encodeId=a8af328222d1, content=优质资源.共同学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib06iaV3D9Tg5K0LqDY57Aia0TOQByoJhNt3icm4sfukp500hLH6RHOpFdV01NbECtAV7s0qKpQPibyRukQAwAmqJU3X/0, createdBy=f91f1928792, createdName=九九消寒, createdTime=Sat Jun 30 13:20:59 CST 2018, time=2018-06-30, status=1, ipAttribution=)]
    2018-06-30 九九消寒

    优质资源.共同学习

    0

相关资讯

结肠癌伴多发性肝转移转化治疗病例

患者女性,47岁。2017-11-01因“上腹部疼痛20余日”入院

Gastroenterology :直接反映腺瘤检测和切除的结肠镜筛查新指标

研究人员考察了2种全新的直肠癌乙状结肠镜筛查指标,新指标可以直接反映腺瘤的检测和切除,较筛查频率相比能更有效的指导胃肠外科的临床实践过程

Gastroenterology :AI图像系统可大大提高结肠镜腺瘤检出率

研究发现,图像分析AI技术可以快速定位息肉,对结肠息肉具有极高的检出率及准确性, 可大大提高结肠腺瘤检出率

JAMA Surg:结肠癌患者不同全直肠系膜切除术方案与预后

研究证实不同的结肠癌手术方案对患者长期预后及临床效果的影响显著

JAMA:呋喹替尼三线治疗转移性结肠癌效果显著

研究认为,对于接受过2种化疗方案的转移性结肠癌患者,呋喹替尼治疗可显著延长患者生存期

Lancet:新辅助化疗后实现完全缓解的结肠癌患者可推迟手术

研究发现,新辅助化疗后实现完全缓解患者不接受手术治疗的5年生存率可达85%,晚期病变罕见,但患者2年内局部复发风险较高,且复发位点均位于肠壁处,这表明延期手术患者接受规律的内镜监测是十分重要的